Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy
for
Early-stage Breast Cancer
Location: Ottawa, Kingston, Oshawa
Sponsor: Ottawa Hospital Research Institute
Sex: All
Age: 18+
Code: NCT05753618
Recruiting
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
for
Triple Negative Locally Advanced Non-resectable Breast Cancer,
Location: Boston MA, Toronto, Columbus OH, Nashville TN,
Sponsor: Marengo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06827613
Phase1, Phase2, Recruiting
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study
for
Breast Cancer
Location: New York NY, Brooklyn NY
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 19 - 70+
Code: NCT04371913
Recruiting
Definitive Radiation for High-Risk Spine Metastases
for
Metastatic Cancer, Metastatic Lung Cancer,
Location: Stony Brook NY
Sponsor: Stony Brook University
Sex: All
Age: 18+
Code: NCT06165419
Phase2, Recruiting
Rowing Following Breast Cancer Chemotherapy
for
Breast Cancer Survivors
Location: Gainesville FL
Sponsor: University of Florida
Sex: Female
Age: 40 - 70+
Code: NCT05848141
Recruiting
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors